newsfilter
← Latest News
Business Wire·

Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow

Charles River Laboratories International, Inc. (NYSE:CRL) today announced continued momentum in its digital pathology platform, delivering an end-to-end, AI-enabled workflow that significantly accelerates study